Harvard Bioscience Inc (HBIO) — 10-Q Filings
All 10-Q filings from Harvard Bioscience Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Harvard Bioscience Plunges into Deeper Loss Amidst Goodwill Impairment
— Nov 6, 2025 Risk: high
HARVARD BIOSCIENCE, INC. (HBIO) reported a significant net loss of $53.853 million for the nine months ended September 30, 2025, a substantial increase from the -
Harvard Bioscience Swings to Loss Amid Rising Costs
— Aug 11, 2025 Risk: medium
HARVARD BIOSCIENCE INC (HBIO) reported a mixed financial performance for the six months ended June 30, 2025. Revenue from continuing operations increased to $55 -
Harvard Bioscience Q1 2025 10-Q Filed
— May 12, 2025 Risk: medium
Harvard Bioscience Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational segments, including specif -
Harvard Bioscience Files Q3 2024 10-Q
— Nov 8, 2024 Risk: low
Harvard Bioscience Inc. reported its Q3 2024 results, with the filing period ending September 30, 2024. The company's fiscal year ends on December 31st. The fil -
Harvard Bioscience Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
Harvard Bioscience Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quar -
Harvard Bioscience Inc. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: medium
HARVARD BIOSCIENCE INC (HBIO) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Revenue for Q1 2024 was not explicitly stated but is implied to be wi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX